ICAM1 and non-small cell lung carcinoma: In the last few years, an increase in soluble ICAM-1 (sICAM-1) expression has been highlighted in several solid tumors, such as gastrointestinal cancer, melanoma, breast cancer, and non-small-cell lung cancer (NSCLC), which is correlated with advanced disease stage and aggressive tumor behavior [59].